QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online June 16, 2005
Journal of Experimental Biology 208, 2467-2474 (2005)
Published by The Company of Biologists 2005
doi: 10.1242/jeb.01667

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JEB Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Terwilliger, N. B. Articles by Towle, D. Search for Related Content PubMed PubMed Citation Articles by Terwilliger, N. B. Articles by Towle, D.

Evolution of novel functions: cryptocyanin helps build new exoskeleton in Cancer magister

N. B. Terwilliger^1,*, M. C. Ryan¹ and D. Towle²

¹ Oregon Institute of Marine Biology, University of Oregon, Box 5389, Charleston, OR 97420, USA
² Mount Desert Island Biological Laboratory, Salsbury Cove, ME 04672, USA

^* Author for correspondence (e-mail: nterwill{at}darkwing.uoregon.edu)

Accepted 26 April 2005

Hemocyanin, the blue blood protein of many arthropods and molluscs, reversibly binds oxygen at its highly conserved copper–oxygen-binding sites and supplies tissues with oxygen. Cryptocyanin, closely related structurally and phylogenetically to arthropod hemocyanin, lacks several of the six critical copper-binding histidines, however, and has lost the ability to bind oxygen. Despite this loss of function, cryptocyanin continues to be synthesized, an indication that it has been exploited to carry out new functions. Here, we show that cryptocyanin is present in extremely high concentrations in the hemolymph of the crab during the premolt portion of the molt cycle. Both proteins are specifically expressed in the same type of cell in the hepatopancreas and secreted into the hemolymph, but cryptocyanin plays a major role in forming the new exoskeleton, while hemocyanin functions in oxygen transport. A cessation in cryptocyanin, but not hemocyanin, synthesis after eyestalk ablation supports our hypothesis that cryptocyanin is closely regulated by molting hormones. The contrasts between the two gene products illustrate how a gene duplication of a copper–oxygen protein and its subsequent mutation may work in concert with the evolution of new regulatory mechanisms, leading to the assumption of new functions.

Key words: Cancer magister, cryptocyanin, hemocyanin, ecdysis, exoskeleton, Crustacea

Related articles in JEB:

BLUE BLOODS: HOW A CRAB MAKES ITS SHELL

Yfke van Bergen
JEB 2005 208: ii. [Full Text]  

This article has been cited by other articles:

				H. Decker, N. Hellmann, E. Jaenicke, B. Lieb, U. Meissner, and J. Markl Minireview: Recent progress in hemocyanin research Integr. Comp. Biol., October 1, 2007; 47(4): 631 - 644. [Abstract] [Full Text] [PDF]

				N. B. Terwilliger, M. Ryan, and M. R. Phillips Crustacean hemocyanin gene family and microarray studies of expression change during eco-physiological stress Integr. Comp. Biol., December 1, 2006; 46(6): 991 - 999. [Abstract] [Full Text] [PDF]

				N. B. Terwilliger and M. C. Ryan Functional and Phylogenetic Analyses of Phenoloxidases from Brachyuran (Cancer magister) and Branchiopod (Artemia franciscana, Triops longicaudatus) Crustaceans. Biol. Bull., February 1, 2006; 210(1): 38 - 50. [Abstract] [Full Text] [PDF]

				Y. van Bergen BLUE BLOODS: HOW A CRAB MAKES ITS SHELL J. Exp. Biol., July 1, 2005; 208(13): ii - ii. [Full Text] [PDF]